viewWeedMD Inc

WeedMD subsidiary Starseed Medicinal awarded cannabis research license

The license allows the Toronto-based medical marijuana firm to test cannabis concentrates that pertain to vape products in development testing

vape pen cannabis
Research will look at the best ways to handle and store cannabis

WeedMD Inc (CVE:WMD) (OTCMKTS:WDDMF) subsidiary Starseed Medicinal Inc received its cannabis research license from Health Canada, the company announced Thursday.

The license allows the Toronto-based medical marijuana firm to test cannabis concentrates that pertain to vape products in development testing at its Bowmanville, Ontario facility.

WeedMD CEO Angelo Tsebelis told shareholders that the company was committed to developing new cannabis products for its customers.

READ: WeedMD subsidiary Starseed Medicinal adds benefits provider myHSA to its medical cannabis program

“With the evolution of next-generation cannabis products such as extracts for vaporization, we want to ensure we drive important data collection forward on behalf of our patients and consumers,” Tsebelis said in a statement.

“We are diligently assessing new cannabis products - in this case, specific to vapes - to determine optimum formulations that will result in the best performance and delivery of medical cannabis, as well as consumer acceptability.”

According to WeedMD, the research license gives way to activities and protocols that involve direct handling and storage of cannabis while also allowing for the administration and distribution of cannabis to focus group subjects for feedback. The program is also expected to evaluate the effect of storage conditions on vape cartridges to ensure product stability over time.

WeedMD acquired Starseed Holdings in December 2019.

The firm also said that as part of the acquisition it was granting nearly 5.7 million options at C$0.98 per share expiring November 3, 2022, and just over 900,000 WeedMD option with an exercise price of C$3.26 per share expiring on November 1, 2023.

Contact Angela at angela@proactiveinvestors.com

Follow her on Twitter @AHarmantas

Quick facts: WeedMD Inc

Price: 0.315 CAD

Market: TSX-V
Market Cap: $66.23 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of WeedMD Inc named herein, including the promotion by the Company of WeedMD Inc in any Content on the Site, the Company receives from said issuer...


Buds & Duds: Cannabis stocks off to slow start to the holidays; WeedMD rises...

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, fell 1.8% to settle at 115.4 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF lost 2.1% at C$8.99, while the OTCQX Cannabis dropped 2.3% at 444.7 points. Buds today are WeedMD Inc...

on 2/12/19

2 min read